News from jazz pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 15, 2015, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...

May 07, 2015, 16:05 ET

Jazz Pharmaceuticals Announces First Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2015 and reaffirmed...

Apr 23, 2015, 16:05 ET

Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 first quarter financial results on Thursday, May 7,...

Feb 24, 2015, 16:05 ET

Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2014 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter ended December 31, 2014 and...

Feb 23, 2015, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...

Feb 12, 2015, 08:30 ET

Jazz Pharmaceuticals to Present Data on Defibrotide, an Investigational Treatment, in Patients with Hepatic Veno-Occlusive Disease (VOD) at BMT Tandem Meetings

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present data on the use of defibrotide, an investigational...

Feb 10, 2015, 16:05 ET

Jazz Pharmaceuticals to Report 2014 Fourth Quarter and Full Year Financial Results on February 24, 2015

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 fourth quarter and full year financial results on Tuesday,...

Jan 05, 2015, 16:05 ET

Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 12

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 33rd Annual J.P....

Dec 19, 2014, 19:05 ET

Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze® (asparaginase Erwinia chrysanthemi)

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous...

Dec 11, 2014, 16:05 ET

Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the initiation of a rolling submission of a New Drug Application (NDA) to the United...

Dec 02, 2014, 16:05 ET

Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patients have been enrolled in a Phase 3 clinical trial to assess the...

Dec 02, 2014, 16:05 ET

Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present the results of a number needed to treat (NNT; an...

Nov 25, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...

Nov 06, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...

Nov 04, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2014 and updated financial...

Oct 21, 2014, 16:05 ET

Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 third quarter financial results on Tuesday, November 4,...

Aug 08, 2014, 06:30 ET

Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), priced...

Aug 06, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), intends to...

Aug 05, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter ended June 30, 2014 and updated financial...

Aug 05, 2014, 16:01 ET

Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of its acquisition of rights to defibrotide in the United States (U.S.)...